nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo searchdiv qikanlogo popupnotification paper paperNew
2025, 07, v.66 680-684
从“郁、热、虚、瘀、毒”病机演变探讨心血管-肾脏-代谢综合征的中医药防治
基金项目(Foundation): 北京中医药大学基本科研业务费揭榜挂帅重点项目(2024-JYB-JBZD-011); 北京中医药大学东直门医院高水平医院项目—领军人才(DZMG-LJRC0001); 国家中医药管理局高水平中医药重点学科建设项目(zyyzdxk-2023255)
邮箱(Email): zhaojinximd@126.com;
DOI: 10.13288/j.11-2166/r.2025.07.005
摘要:

中医药防治心血管-肾脏-代谢综合征(CKM)具有丰富的理论基础和临床经验,亦具有疗效优势。结合前期防治糖尿病及其并发症以及慢性肾脏病相关工作实践,提出CKM不同分期的核心病机理论,即“郁、热、虚、瘀、毒”,分别对应痰湿内郁、内郁化热、热伤气阴、络脉瘀结、虚瘀成毒的病机演变过程。在中医药防治CKM的实践中,强调将“治未病”理念与体质学说相结合,融入“二、五、八”防治方案,形成寓防于治、防治结合、分期辨证、综合治疗的防治方案,以发挥中医药整体防治优势。

Abstract:

Traditional Chinese medicine(TCM) offers a rich theoretical foundation and clinical experience for the prevention and treatment of cardiovascular-kidney-metabolic syndrome(CKM), demonstrating unique advantage.Building on previous work in managing diabetes, its complications, and chronic kidney disease, our team has proposed a five-phase evolution theory of "constraint, heat, deficiency, stasis, and toxin" as the core pathogenesis. These phases correspond to the pathological progression of constraint of phlegm-dampness, constraint transforming into heat, heat damaging qi and yin, stasis accumulated in the collateral vessels, and toxin induced by deficiency and stasis. In the prevention and treatment of CKM by TCM, it is emphasized to integrate the concept of "treating disease before it arises" with constitution theory, and incorporate the "2-5-8" prevention and treatment strategy, which combines prevention with treatment, tailors interventions to different phases, and employs comprehensive treatment modalities. Our goal is to leverage TCM's holistic advantages in preventing and treating CKM.

参考文献

[1]SEBASTIAN SA, PADDA I, JOHAL G. Cardiovascularkidney-metabolic(CKM)syndrome:a state-of-the-art review[J]. Curr Probl Cardiol, 2024, 49(2):102344.

[2]NDUMELE CE, RANGASWAMI J, CHOW SL, et al.Cardiovascular-kidney-metabolic health:a presidential advisory from the American Heart Association[J].Circulation, 2023, 148(20):1606-1635.

[3]国家心血管病中心,中国心血管健康与疾病报告编写组.中国心血管健康与疾病报告2023概要[J].中国循环杂志,2024, 39(7):625-660.

[4]ARNOLD SV, KOSIBOROD M, WANG J, et al. Burden of cardio-renal-metabolic conditions in adults with type 2diabetes within the diabetes collaborative registry[J].Diabetes Obes Metab, 2018, 20(8):2000-2003.

[5]傅强,王世东,肖永华,等.吕仁和教授分期辨治糖尿病学术思想探微[J].世界中医药,2017, 12(1):21-24.

[6]胡诗宛,王思成,赵林华,等.以“糖络病”为糖尿病中医病名的合理性与临床意义[J].中医杂志,2024, 65(19):1963-1966, 1971.

[7]苟筱雯,赵林华,何莉莎,等.从态靶辨证谈中医治疗2型糖尿病的用药策略[J].辽宁中医杂志,2020, 47(4):1-4.

[8]常成成,魏聪,吴以岭.脉络学说“孙络-微血管”概念及其临床指导意义[J].中医杂志,2016, 57(1):7-11.

[9]邢海涛,杨波,曹式丽.从“血不利则为水”探析心肾综合征的发病机制[J].江苏中医药,2013, 45(3):4-6.

[10]周育平,胡元会,张振鹏,等.运用交通心肾理论治疗心肾综合征浅析[J].中国中医药信息杂志,2010,17(6):89-90.

[11]李宁荫,李秀丽,翟晓萍,等.黄芪对高血压病合并代谢综合征患者早期心肾保护的临床研究[J].中国中药杂志,2016, 41(21):4051-4059.

[12]史晨旭,杜佳蓉,吴威,等.葛根化学成分及药理作用研究进展[J].中国现代中药,2021, 23(12):2177-2195.

[13]万新焕,王瑜亮,周长征,等.丹参化学成分及其药理作用研究进展[J].中草药,2020, 51(3):788-798.

[14]李景,赵进喜,王世东,等.中医药综合治疗方案全程干预对糖尿病肾病终点事件的影响[J].中医杂志,2012, 53(7):568-571, 580.

[15]POWELL-WILEY TM, POIRIER P, BURKE LE, et al.Obesity and cardiovascular disease:a scientific statement from the American Heart Association[J]. Circulation,2021, 143(21):e984-e1010.

[16]GRUNDY SM. Metabolic syndrome update[J]. Trends Cardiovasc Med, 2016, 26(4):364-373.

[17]赵进喜,冯兴中,仝小林,等.论糖尿病的中医核心病机与基本治法[J].北京中医药,2019, 38(1):3-6.

[18]吴巧茹,王耀献,杨涵雯,等.糖尿病肾脏病“内热致癥”病机内涵[J].中医学报,2023, 38(5):927-931.

[19]丁英钧,肖永华,傅强,等.糖尿病肾病“微型癥瘕”病理假说解析[J].中华中医药杂志,2009, 24(1):27-30.

[20]王阶,邢雁伟,姚魁武,等.冠心病“痰瘀滞虚”理论内涵与外延[J].中医杂志,2019, 60(4):280-284.

[21]刘宁,赵进喜,贾海忠,等.毒邪致病,急危疑难;从毒论治,重在审因[J].环球中医药,2021, 14(12):2166-2169.

[22]赵进喜,倪博然,王世东,等.三阴三阳体质学说及其研究述评[J].中华中医药杂志,2018, 33(11):4807-4812.

[23]罗文轩,赵进喜,魏金艳,等.论代谢病胃强脾弱的病机与治法[J].中医杂志,2024, 65(19):2041-2044, 2049.

[24]张海力,李靖,高彤彤,等.吕仁和教授应用“二、五、八”方案管理糖尿病肾病患者经验总结[J].世界中医药,2019,14(11):3028-3031.

[25]胡洁,傅强,刘媛媛,等.基于“六郁”与“郁热”理论探讨吕仁和分期论治糖尿病[J].浙江中医药大学学报,2023, 47(11):1300-1305, 1310.

[26]胡志鹏,杨茂艺,秦凯华,等.浅谈风药治疗血瘀证[J].中医杂志,2018, 59(20):1791-1793.

[27]刘轶凡,赵进喜,傅强,等.糖尿病肾脏病“风邪伏络”对“微型癥瘕”的继承发展与“从风治瘀”思路[J].中华中医药杂志,2024, 39(3):1181-1184.

[28]赵进喜,庞博.中医学“浊”的涵义及其临床意义[J].中医杂志,2009, 50(7):581-584.

[29]申子龙,赵进喜,王世东,等.赵进喜治疗肾脏病水肿五法[J].世界中医药,2015, 10(11):1748-1751.

[30]邓德强.赵进喜“三维护肾疗法”治疗肾病经验撷菁[J].江苏中医药,2006, 27(7):20-21.

基本信息:

DOI:10.13288/j.11-2166/r.2025.07.005

中图分类号:R259;R277.5

引用信息:

[1]阮智超,刘江腾,张华等.从“郁、热、虚、瘀、毒”病机演变探讨心血管-肾脏-代谢综合征的中医药防治[J].中医杂志,2025,66(07):680-684.DOI:10.13288/j.11-2166/r.2025.07.005.

基金信息:

北京中医药大学基本科研业务费揭榜挂帅重点项目(2024-JYB-JBZD-011); 北京中医药大学东直门医院高水平医院项目—领军人才(DZMG-LJRC0001); 国家中医药管理局高水平中医药重点学科建设项目(zyyzdxk-2023255)

检 索 高级检索

引用

GB/T 7714-2015 格式引文
MLA格式引文
APA格式引文